• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在催化二氢香豆素转化过程中,重组对氧磷酶 1 依赖于底物的失活以及表面活性剂的保护特性。

Substrate-dependent inactivation of recombinant paraoxonase 1 during catalytic dihydrocoumarin turnover and the protective properties of surfactants.

机构信息

Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI 1000, Ljubljana, Slovenia.

Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Vrazov trg 2, SI 1000, Ljubljana, Slovenia.

出版信息

Chem Biol Interact. 2023 Sep 1;382:110563. doi: 10.1016/j.cbi.2023.110563. Epub 2023 Jun 5.

DOI:10.1016/j.cbi.2023.110563
PMID:37286155
Abstract

Human paraoxonase-1 (PON1) is the most studied member of the paraoxonases (PONs) family and catalyzes the hydrolysis of various substrates (lactones, aryl esters, and paraoxon). Numerous studies link PON1 to oxidative stress-related diseases such as cardiovascular disease, diabetes, HIV infection, autism, Parkinson's, and Alzheimer's, where the kinetic behavior of an enzyme is characterized by initial rates or by modern methods that obtain enzyme kinetic parameters by fitting the computed curves over the entire time-courses of product formation (progress curves). In the analysis of progress curves, the behavior of PON1 during hydrolytically catalyzed turnover cycles is unknown. Hence, progress curves for enzyme-catalyzed hydrolysis of the lactone substrate dihydrocoumarin (DHC) by recombinant PON1 (rePON1) were analyzed to investigate the effect of catalytic DHC turnover on the stability of rePON1. Although rePON1 was significantly inactivated during the catalytic DHC turnover, its activity was not lost due to the product inhibition or spontaneous inactivation of rePON1 in the sample buffers. Examination of the progress curves of DHC hydrolysis by rePON1 led to the conclusion that rePON1 inactivates itself during catalytic DHC turnover hydrolysis. Moreover, human serum albumin or surfactants protected rePON1 from inactivation during this catalytic process, which is significant because the activity of PON1 in clinical samples is measured in the presence of albumin.

摘要

人对氧磷酶 1(PON1)是对氧磷酶(PONs)家族中研究最多的成员,能够催化各种底物(内酯、芳基酯和对氧磷)的水解。大量研究将 PON1 与氧化应激相关疾病联系起来,如心血管疾病、糖尿病、HIV 感染、自闭症、帕金森病和阿尔茨海默病,其中酶的动力学行为通过初始速率或现代方法来表征,这些方法通过拟合整个产物形成的时间过程(进展曲线)来获得酶动力学参数。在进展曲线的分析中,未知 PON1 在水解催化周转循环期间的行为。因此,通过重组 PON1(rePON1)对内酯底物二氢香豆素(DHC)的酶促水解进行的进展曲线进行了分析,以研究催化 DHC 周转对 rePON1 稳定性的影响。尽管 rePON1 在催化 DHC 周转过程中明显失活,但由于产物抑制或 rePON1 在样品缓冲液中的自发失活,其活性并未丧失。对 rePON1 催化 DHC 水解的进展曲线的检查得出结论,rePON1 在催化 DHC 水解周转过程中使自身失活。此外,人血清白蛋白或表面活性剂在催化过程中保护 rePON1 不被失活,这一点很重要,因为在白蛋白存在的情况下测量临床样本中的 PON1 活性。

相似文献

1
Substrate-dependent inactivation of recombinant paraoxonase 1 during catalytic dihydrocoumarin turnover and the protective properties of surfactants.在催化二氢香豆素转化过程中,重组对氧磷酶 1 依赖于底物的失活以及表面活性剂的保护特性。
Chem Biol Interact. 2023 Sep 1;382:110563. doi: 10.1016/j.cbi.2023.110563. Epub 2023 Jun 5.
2
Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.血清对氧磷酶PON1的结构-反应活性研究表明,其天然活性为内酯酶。
Biochemistry. 2005 Apr 26;44(16):6371-82. doi: 10.1021/bi047440d.
3
Stereo-specific synthesis of analogs of nerve agents and their utilization for selection and characterization of paraoxonase (PON1) catalytic scavengers.立体选择性合成神经毒剂类似物及其用于对氧磷酶(PON1)催化清除剂的选择和表征。
Chem Biol Interact. 2010 Sep 6;187(1-3):362-9. doi: 10.1016/j.cbi.2010.02.039. Epub 2010 Mar 19.
4
HDL3 stimulates paraoxonase 1 antiatherogenic catalytic and biological activities in a macrophage model system: in vivo and in vitro studies.HDL3在巨噬细胞模型系统中刺激对氧磷酶1的抗动脉粥样硬化催化活性和生物学活性:体内和体外研究
Biofactors. 2014 Sep-Oct;40(5):536-45. doi: 10.1002/biof.1184. Epub 2014 Sep 18.
5
In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.体内给予BL-3050:高度稳定的工程化对氧磷酶1-高密度脂蛋白复合物。
BMC Clin Pharmacol. 2009 Nov 17;9:18. doi: 10.1186/1472-6904-9-18.
6
Engineered Recombinant PON1-OPH Fusion Hybrids: Potentially Effective Catalytic Bioscavengers against Organophosphorus Nerve Agent Analogs.工程化重组 PON1-OPH 融合杂合体:对抗有机磷神经毒剂类似物的潜在有效催化生物清除剂。
J Microbiol Biotechnol. 2021 Jan 28;31(1):144-153. doi: 10.4014/jmb.2006.06044.
7
Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs.重组对氧磷酶 1 可预防沙林和梭曼吸入微滴暴露对豚鼠的毒性。
Toxicol Lett. 2011 May 10;202(3):203-8. doi: 10.1016/j.toxlet.2011.02.007. Epub 2011 Feb 15.
8
Paraoxonase 1 hydrolysis of EPA-derived lactone impairs endothelial-mediated vasodilation.对氧磷酶 1 水解 EPA 衍生内酯会损害内皮介导的血管舒张。
Prostaglandins Other Lipid Mediat. 2022 Oct;162:106665. doi: 10.1016/j.prostaglandins.2022.106665. Epub 2022 Jul 9.
9
Catalytic versatility and backups in enzyme active sites: the case of serum paraoxonase 1.酶活性部位的催化多功能性和备用机制:血清对氧磷酶 1 案例。
J Mol Biol. 2012 May 4;418(3-4):181-96. doi: 10.1016/j.jmb.2012.02.042. Epub 2012 Mar 1.
10
In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates.不同来源对氧磷酶 1 对各种有机磷化合物的体外疗效。
Toxicol In Vitro. 2011 Jun;25(4):905-13. doi: 10.1016/j.tiv.2011.02.012. Epub 2011 Mar 5.

引用本文的文献

1
Affinity Electrophoresis of Proteins for Determination of Ligand Affinity and Exploration of Binding Sites.用于测定配体亲和力和探索结合位点的蛋白质亲和电泳
Int J Mol Sci. 2025 Apr 5;26(7):3409. doi: 10.3390/ijms26073409.